Reinsurance Group (RGA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Reinsurance Group (RGA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New business volumes, favorable longevity experience, a diversified business, effective capital deployment and higher return on capital poise RGA for growth.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Reinsurance Group of America has surged over 50% in the past year, driven by strong underwriting results and higher interest income. Despite recent volatility, RGA's strategic capital deployment into pension risk transfer deals and a $3.5 billion coinsurance deal with American National bolsters growth. RGA's robust balance sheet, high-quality investment portfolio, and strong premium growth justify a "buy" rating with my fair value target of $250.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New business volumes, favorable longevity experience, a diversified business, effective capital deployment and cheap valuation make RGA worth betting on.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
RGA shares dipped 14.12% on August 2 and 5, presenting a buying opportunity. The company specializes in life and health reinsurance, showing steady growth and financial strength. Strong Buy rating with one-year price target of $239.09, supported by earnings growth and dividend increases.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.